Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu
At AACR 2026, the Genialis™ Supermodel–powered RNA survival model [...]
The Pulse of the Oncologist: Meeting clinicians and patients where they are to deliver precision medicine | TPM podcast #55
Upcoming events AACR 2026 [...]
An RNA-based survival model predicting real-world response to trastuzumab deruxtecan
Antibody-drug conjugates (ADCs) like trastuzumab deruxtecan (T-DXd, Enhertu) have [...]
The rhythm and dissonance of cancer biology | TPM podcast #54
Upcoming events Genialis on LinkedIn [...]
Visual analytics framework for survival analysis and biomarker discovery from gene expression data
We introduce a visual analytics methodology for survival analysis, [...]
Be the change you want to see in the world: mobilizing to protect American science | TPM podcast #53
Upcoming events Genialis on LinkedIn [...]
Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
Genialis Expressions empowers drug development teams to make confident [...]
When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52
Get in touch TPM podcast archive [...]
Frequency of driver mutations across disease stages in Slovenian non-small cell lung cancer patients
This poster presents the first comprehensive analysis of actionable [...]
From platform to portfolio: Using AI to derisk gene therapy and genetic medicine | TPM podcast #51
ESMO AI 2025 poster TPM podcast [...]
